Phone: +44 (0)1462 439877 Email: email@example.com
To ensure a smooth transition from the pre-authorisation to the post-authorisation phase of the life-cycle of a ...
31 Jul, 2019
What you need to know about the GVP Paediatric Guideline
25 Sep, 2019
QPPV and PSMF requirements in case of a no-deal Brexit
17 Sep, 2019
A Guide to the US FDA Safety Requirements for Pharmacovigilance